Effects of IGF2BP2, KCNQ1 and GCKR polymorphisms on clinical outcome in metastatic gastric cancer treated with EOF regimen

Oncogenic NRAS, Required for Pathogenesis of Embryonic Rhabdomyosarcoma, Relies upon the HMGA2-IGF2BP2 Pathway

(2013) Z. Li et al.   CANCER RESEARCH

The role of KCNQ1 in mouse and human gastrointestinal cancers

(2013) B L N Than et al.   ONCOGENE

Genetic Polymorphisms at TIMP3 Are Associated with Survival of Adenocarcinoma of the Gastroesophageal Junction

(2013) Morteza Bashash et al.   PLoS One

ERCC1 and ERCC2 Variants Predict Survival in Gastric Cancer Patients

(2013) Yangkai Li et al.   PLoS One

Diabetes mellitus carries a risk of gastric cancer: A meta-analysis

(2013) Shouji Shimoyama   WORLD JOURNAL OF GASTROENTEROLOGY

Genetic Variants, Prediagnostic Circulating Levels of Insulin-like Growth Factors, Insulin, and Glucose and the Risk of Colorectal Cancer: The Multiethnic Cohort Study

(2012) N. J. Ollberding et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Effect of Type 2 Diabetes Predisposing Genetic Variants on Colorectal Cancer Risk

(2012) Juan Sainz et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

IMP-1 Displays Cross-Talk with K-Ras and Modulates Colon Cancer Cell Survival through the Novel Proapoptotic Protein CYFIP2

(2011) P. S. Mongroo et al.   CANCER RESEARCH

Genes Related to Diabetes May Be Associated With Pancreatic Cancer in a Population-Based Case-Control Study in Minnesota

(2011) Anna E. Prizment et al.   PANCREAS

Diabetes Genes and Prostate Cancer in the Atherosclerosis Risk in Communities Study

(2010) T. E. Meyer et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Insulin-Mediated Acceleration of Breast Cancer Development and Progression in a Nonobese Model of Type 2 Diabetes

(2010) R. Novosyadlyy et al.   CANCER RESEARCH

Diabetes conveys a higher risk of gastric cancer mortality despite an age-standardised decreasing trend in the general population in Taiwan

(2010) C.-H. Tseng   GUT

New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk

(2010) Josée Dupuis et al.   NATURE GENETICS

Host genetic variants in the IGF binding protein-3 impact on survival of patients with advanced gastric cancer treated with palliative chemotherapy

(2010) Francesco Graziano et al.   PHARMACOGENOMICS

Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial

(2009) Y.-K. Kang et al.   ANNALS OF ONCOLOGY

Gastric carcinogenesis byN-Methyl-N-Nitrosourea is enhanced in db/db diabetic mice

(2009) Nao Yoshizawa et al.   CANCER SCIENCE

Confirmation of Multiple Risk Loci and Genetic Impacts by a Genome-Wide Association Study of Type 2 Diabetes in the Japanese Population

(2009) F. Takeuchi et al.   DIABETES

A Transposon-Based Genetic Screen in Mice Identifies Genes Altered in Colorectal Cancer

(2009) T. K. Starr et al.   SCIENCE

TP53 codon 72 polymorphism associated with prognosis in patients with advanced gastric cancer treated with paclitaxel and cisplatin

(2008) Jong Gwang Kim et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

The Common P446L Polymorphism in GCKR Inversely Modulates Fasting Glucose and Triglyceride Levels and Reduces Type 2 Diabetes Risk in the DESIR Prospective General French Population

(2008) M. Vaxillaire et al.   DIABETES

Hyperglycemia Increases Risk of Gastric Cancer Posed by Helicobacter pylori Infection: A Population-Based Cohort Study

(2008) Fumie Ikeda et al.   GASTROENTEROLOGY

Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus

(2008) Kazuki Yasuda et al.   NATURE GENETICS

SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations

(2008) Hiroyuki Unoki et al.   NATURE GENETICS

Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer

(2008) David Cunningham et al.   NEW ENGLAND JOURNAL OF MEDICINE